ATLAS fair value
ATLAS has no fair value for this stock today.
Jw stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Korea Exchange (KOSPI) · South Korea
Prices as of Oct 27, 2026 · KRW
ATLAS has no fair value for this stock today.
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Jw a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩3,735 and ₩4,105; in 9 out of 10, between ₩3,435 and ₩4,464. Estimated annual volatility is 26%.
ATLAS does not publish a fair value for 096760.KO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 096760.KO has traded between ₩3,195 and ₩4,720. Today it is 17.3% below that high and 22% above its low.
On the business: net margin is 8.4%; it trades at 3.3 times earnings.
Its beta is 0.56: it tends to move less than the market.
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
Want to see everything about Jw?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
52%: close to a coin flip. In half of the simulated outcomes, 096760.KO ends the month between ₩3,735 and ₩4,105.
Jw's market capitalization is ₩272B. Its price-to-earnings (P/E) ratio is 3.3: you pay ₩3.30 for each ₩1.00 of yearly earnings.
Yes. 096760.KO's current dividend yield is 5.34% at today's price (₩3,905).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy